Skip to main content
Signal8
Graff Jeremy R. profile photo

Jeremy R. Graff

CIK: 0001975028

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (20.0%)

Derivative conversions

Awards (A)8 (53.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (26.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Allarity Therapeutics, Inc. logo
ALLR

Allarity Therapeutics, Inc.

Officer
IN8BIO, INC. logo
INAB

IN8BIO, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Sep 30, 2026
    Tax Payment(F)
    Direct
    14.6K shares at avg. $0.97$14K
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Sep 30, 2026
    Exercise(M)
    Direct
    39.5K shares-
  • IN8BIO, INC. logo
    INAB

    IN8BIO, INC.

    May 9, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    22K shares-
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Jan 28, 2026
    Award(A)
    Direct
    133.3K shares-
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Jan 22, 2026
    Exercise(M)
    Direct
    48.1K shares-
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Jan 22, 2026
    Tax Payment(F)
    Direct
    17.8K shares at avg. $1.18$21K
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Jan 7, 2026
    Award(A)
    Direct
    133.3K shares-
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Sep 30, 2025
    Exercise(M)
    Direct
    39.5K shares-
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Sep 30, 2025
    Tax Payment(F)
    Direct
    14.6K shares at avg. $1.58$23K
  • IN8BIO, INC. logo
    INAB

    IN8BIO, INC.

    May 8, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    63.2K shares-
  • IN8BIO, INC. logo
    INAB

    IN8BIO, INC.

    Apr 27, 2025
    Award(A)

    Series B Warrants (right to buy)

    Direct
    2K shares-
  • IN8BIO, INC. logo
    INAB

    IN8BIO, INC.

    Apr 27, 2025
    Disposition(D)

    Series B Warrants (right to buy)

    Direct
    2K shares-
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Jan 22, 2025
    Award(A)
    Direct
    144.4K shares-
  • IN8BIO, INC. logo
    INAB

    IN8BIO, INC.

    Dec 19, 2024
    Award(A)

    Stock Option (right to buy)

    Direct
    47.7K shares-
  • Allarity Therapeutics, Inc. logo
    ALLR

    Allarity Therapeutics, Inc.

    Sep 30, 2024
    Award(A)
    Direct
    118.5K shares at avg. $2.11$250K

1-15 of 15

About Graff Jeremy R.

Graff Jeremy R. (SEC CIK 0001975028) files insider reports with the SEC as Officer of Allarity Therapeutics, Inc. (ALLR) and Director of IN8BIO, INC. (INAB).

Signal8 holds 11 ownership filings by Graff Jeremy R. (1 Form 3, 10 Form 4), filed between Oct 1, 2024 and Oct 9, 2026. Those filings report 15 transactions, from Sep 30, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Graff Jeremy R.'s filings is in TARPON SPRINGS, FL.

Recent filings by Graff Jeremy R.

  • Sep 30, 2026: Tax withholding of ALLR shares (Form 4, code F).
  • Sep 30, 2026: Option exercise of ALLR shares (Form 4, code M).
  • May 9, 2026: Grant or award of INAB derivative securities (Form 4, code A).
  • Jan 28, 2026: Grant or award of ALLR shares (Form 4, code A).
  • Jan 22, 2026: Option exercise of ALLR shares (Form 4, code M).

Other insiders filing for Allarity Therapeutics, Inc. (ALLR)

How to read Form 4 transaction codes